Feng Chi Biotech Corp.(TW:6744)
NT$12.900.00 (0.00%)
TW:6744
Feng Chi Biotech Corp. financials statements
NT$12.90
At close:0.00 (0.00%)
Feng Chi Biotech Corp. (6744) Financial Statements
Feng Chi Biotech Corp. Financial Overview
Feng Chi Biotech Corp.'s market cap is currently NT$189.50M. The company's EPS TTM is NT$0.65; its P/E ratio is 19.54; and it has a dividend yield of 6.51%. Feng Chi Biotech Corp. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 177.36M | NT$ 171.10M | NT$ 180.58M | NT$ 193.46M | NT$ 182.57M |
| Gross Profit | NT$ 79.16M | NT$ 77.15M | NT$ 79.60M | NT$ 83.44M | NT$ 86.11M |
| Operating Income | NT$ 13.85M | NT$ 16.12M | NT$ 24.16M | NT$ 27.07M | NT$ 26.44M |
| EBITDA | NT$ 25.97M | NT$ 29.80M | NT$ 34.84M | NT$ 36.79M | NT$ 36.96M |
| Net Income | NT$ 14.47M | NT$ 16.59M | NT$ 22.79M | NT$ 24.61M | NT$ 23.14M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 178.63M | NT$ 207.68M | NT$ 216.44M | NT$ 235.41M | NT$ 230.78M |
| Total Assets | NT$ 287.91M | NT$ 299.07M | NT$ 301.03M | NT$ 308.36M | NT$ 286.69M |
| Total Debt | NT$ 5.43M | NT$ 8.15M | NT$ 10.80M | NT$ 13.48M | NT$ 2.55M |
| Net Debt | NT$ -11.96M | NT$ -18.10M | NT$ -19.81M | NT$ -52.42M | NT$ -46.26M |
| Total Liabilities | NT$ 48.01M | NT$ 59.19M | NT$ 63.03M | NT$ 72.49M | NT$ 56.18M |
| Stockholders' Equity | NT$ 239.90M | NT$ 239.88M | NT$ 238.00M | NT$ 235.87M | NT$ 230.51M |
| Cash Flow | |||||
| Free Cash Flow | NT$ -9.89M | NT$ 10.46M | NT$ 14.02M | NT$ 28.23M | NT$ 31.83M |
| Operating Cash Flow | NT$ 3.24M | NT$ 25.05M | NT$ 15.41M | NT$ 28.49M | NT$ 32.92M |
| Investing Cash Flow | NT$ 5.26M | NT$ -10.60M | NT$ -27.34M | NT$ 10.62M | NT$ -10.97M |
| Financing Cash Flow | NT$ -17.35M | NT$ -18.82M | NT$ -23.37M | NT$ -22.01M | NT$ -20.42M |
Currency in TWD

